2012 National Healthcare Quality and Disparities Reports
Effectiveness of Care: Respiratory Diseases
Vaccinations for Respiratory Infections
High-risk adults who received an influenza vaccination in the last 12 months
Adults age 65 and over who received an influenza vaccination in the last 12 months
Hospital admissions for immunization-preventable influenza per 100,000 population, age 65 and over
High-risk adults ages 18-64 who ever received a pneumococcal vaccination
Adults age 65 and over who ever received pneumococcal vaccination
Treatment of Respiratory Infections
Composite measure: Hospital patients with pneumonia who received recommended hospital care
Hospital patients with pneumonia who had blood cultures collected before antibiotics were administered
Hospital patients with pneumonia who received the initial antibiotic dose within 6 hours of arrival
Hospital patients with pneumonia who received the initial antibiotic consistent with current recommendations
Hospital patients with pneumonia who received influenza screening or vaccination
Hospital patients with pneumonia who received pneumococcal screening or vaccination
Deaths per 1,000 adult hospital admissions with pneumonia
Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment
Bacterial pneumonia admissions per 100,000 adult population in Hawaii
Management of Asthma
People with asthma who are taking daily or almost daily preventive medicine
Hospital admissions for asthma per 100,000 population by age group
People with asthma who receive written asthma management plans from their health care provider
Vaccinations for Respiratory Infections
Measure Title
High-risk adults who received an influenza vaccination in the last 12 months.
Measure Source
Healthy People 2020.
National Tables
2_9_1_1.1 High-risk adults ages 18-64 who received an influenza vaccination in the last 12 months, United States, 2005-2010
2_9_1_1.2 High-risk adults ages 18-64 who received an influenza vaccination in the last 12 months, United States, 2000-2004
2_9_1_1.3a-c High-risk adults ages 18-64 who received an influenza vaccination in the last 12 months, United States, 2010, by:
- Race.
- Ethnicity.
- Family income.
National Data Source
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health Interview Survey (NHIS).
National Denominator
U.S. civilian noninstitutionalized population ages 18-64 who have a high-risk condition.
National Numerator
Subset of the denominator who report receiving an influenza vaccination in the past 12 months.
State Table
2_9_1_1.3 High-risk adults ages 18-64 who received an influenza vaccination in the past 12 months, by State, United States, 2001-2010
State Data Source
Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System (BRFSS).
State Denominator
High-risk adults ages 18-64.
State Numerator
Subset of the denominator who report receiving an influenza vaccination in the past 12 months.
Comments
This measure is referred to as measure IID-12.6 in Healthy People 2020 documentation.
High-risk conditions include diabetes, heart disease, lung disease, kidney disease, liver disease, and cancer. Not all high-risk conditions for complications of influenza can be ascertained by the NHIS (e.g., immunocompromised states), and the sample size may be too small.
Data are age adjusted to the 2000 U.S. standard population.
Race categories have changed since 2001. Data for 2001 and later years may not be comparable with data from previous years.
Vaccinations for Respiratory Infections
Measure Title
Adults age 65 and over who received an influenza vaccination in the last 12 months.
Measure Source
Healthy People 2020.
National Tables
2_9_1_2.1 Adults age 65 and over who received an influenza vaccination in the last 12 months, United States, 2005-2010
2_9_1_2.2 Adults age 65 and over who received an influenza vaccination in the last 12 months, United States, 2000-2004
2_9_1_2.3a-c Adults age 65 and over who received an influenza vaccination in the last 12 months, United States, 2010, by:
- Race.
- Ethnicity.
- Family income.
National Data Source
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health Interview Survey (NHIS).
National Denominator
U.S. civilian noninstitutionalized population of adults age 65 and over.
National Numerator
Number of adults age 65 and over who report receiving an influenza vaccination in the past 12 months.
State Table
2_9_1_2.3 Adults age 65 and over who received an influenza vaccination in the last 12 months, by State, United States, 2001-2010
State Data Source
Centers for Disease Control and Prevention (CDC), Behavioral Risk Factor Surveillance System (BRFSS).
State Denominator
Adults age 65 and over.
State Numerator
Subset of the denominator who report receiving an influenza vaccination in the past 12 months.
Comments
This measure is referred to as measure IID-12.7 in Healthy People 2020 documentation.
Data are age adjusted to the 2000 U.S. standard population.
Vaccinations for Respiratory Infections
Measure Title
Hospital admissions for immunization-preventable influenza per 100,000 population, age 65 and over.
Measure Source
Healthy People 2010.
National Tables
2_9_1_3.1 Admissions for immunization-preventable influenza per 100,000 population, age 65 and over, United States, 2000, 2004-2009
2_9_1_3.2 Admissions for immunization-preventable influenza per 100,000 population, age 65 and over, by race/ethnicity, United States, 2009
2_9_1_3.4 Admissions for immunization-preventable influenza per 100,000 population, age 65 and over, by income, United States, 2000-2009
National Data Source
Agency for Healthcare Research and Quality (AHRQ), Center for Delivery, Organization, and Markets (CDOM), Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample (NIS) and AHRQ Quality Indicators, modified version 4.1.
National Denominator
U.S. population age 65 and over.
National Numerator
Subset of the denominator with any diagnosis of immunization-preventable influenza, excluding transfers from other institutions.
State Table
2_9_1_3.3 Admissions for immunization-preventable influenza per 100,000 population, age 65 and over, by State, United States, 2000, 2004, 2007-2009
State Data Source
AHRQ, CDOM, HCUP, State Inpatient Databases (SID).
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Rates are adjusted by age and gender using the total U.S. population for 2000 as the standard population.
This measure is referred to as measure 1-9c in Healthy People 2010 documentation.
Although not all States participate in the HCUP database, NIS is weighted to give national estimates using weights based on all U.S. community, nonrehabilitation hospitals in the American Hospital Association Annual Survey Database.
SID includes a powerful set of hospital databases from data organizations in participating States. SID contains the universe of the inpatient discharge abstracts in participating States, translated into a uniform format to facilitate multi-State comparisons and analyses. Together, SID encompasses about 90% of all U.S. community hospital discharges. SID contains a core set of clinical and nonclinical information on all patients, regardless of payer, including people covered by Medicare, Medicaid, and private insurance, as well as uninsured people. In addition to the core set of uniform data elements common to all SID, some databases within SID include other elements, such as the patient's race.
The SID disparities analysis file is designed to provide national estimates on disparities using weighted records from a sample of hospitals from the following 31 States: Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Vermont, Wisconsin, and Wyoming.
Vaccinations for Respiratory Infections
Measure Title
High-risk adults ages 18-64 who ever received a pneumococcal vaccination.
Measure Source
Healthy People 2020.
National Tables
2_9_1_4.1 High-risk adults ages 18-64 who ever received a pneumococcal vaccination, United States, 2005-2010
2_9_1_4.2 High-risk adults ages 18-64 who ever received a pneumococcal vaccination, United States, 2000-2004
2_9_1_4.3a-c High-risk adults ages 18-64 who ever received a pneumococcal vaccination, United States, 2010, by:
- Race.
- Ethnicity.
- Family income.
National Data Source
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health Interview Survey (NHIS).
National Denominator
U.S. civilian noninstitutionalized population of adults ages 18-64 with a high-risk condition.
National Numerator
Subset of the denominator who report ever receiving a pneumococcal vaccination.
State Table
2_9_1_4.3 High-risk adults ages 18-64 who ever received a pneumococcal vaccination, by State, United States, 2001-2010
State Data Source
CDC, Behavioral Risk Factor Surveillance System (BRFSS).
State Denominator
Same as national.
State Numerator
Same as national.
Comments
This measure is referred to as measure IID-13.2 in Healthy People 2020 documentation.
Vaccinations for Respiratory Infections
Measure Title
Adults age 65 and over who ever received a pneumococcal vaccination.
Measure Source
Healthy People 2020.
National Tables
2_9_1_5.1 Adults age 65 and over who ever received a pneumococcal vaccination, United States, 2005-2010
2_9_1_5.2 Adults age 65 and over who ever received a pneumococcal vaccination, United States, 2000-2004
2_9_1_5.3a-c Adults age 65 and over who ever received a pneumococcal vaccination, United States, 2010, by:
- Race.
- Ethnicity.
- Family income.
National Data Source
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health Interview Survey (NHIS).
National Denominator
U.S. civilian noninstitutionalized population of adults age 65 and over.
National Numerator
Subset of the denominator who report ever receiving a pneumococcal vaccination.
State Table
2_9_1_5.3 Adults age 65 and over who ever received a pneumococcal vaccination, by State, United States, 2001-2010
State Data Source
CDC, Behavioral Risk Factor Surveillance System (BRFSS).
State Denominator
Adults age 65 and over.
State Numerator
Subset of the denominator who received a pneumococcal vaccination.
Comments
This measure is referred to as measure IID-13.1 in Healthy People 2020 documentation.
Data are age adjusted to the 2000 U.S. standard population.
Treatment of Respiratory Infections
Measure Title
Composite measure: Hospital patients with pneumonia who received recommended hospital care.
Measure Source
Centers for Medicare & Medicaid Services (CMS), Medicare Quality Improvement Organization Program (QIO).
National Table
2_9_2_1.1 Hospital patients with pneumonia who received recommended hospital care, United States, 2007-2010
National Data Source
CMS, QIO.
National Denominator
Medicare hospital discharges age 65 and over meeting either of the following criteria: (1) principal diagnosis of pneumonia or (2) secondary diagnosis of pneumonia and a principal diagnosis of either septicemia or respiratory failure.
National Numerator
Subset of the denominator who received recommended care, if indicated and appropriate.
State Table
2_9_2_1.2 Hospital patients with pneumonia who received recommended hospital care, by State, United States, 2007-2010
State Data Source
CMS, QIO.
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Recommended hospital care practices for pneumonia include:
- Collecting blood cultures before administering the first dose of antibiotics.
- Administering the first dose of antibiotics within 6 hours of patient's arrival at the hospital.
- Administering the recommended empirical antibiotic regimen consistent with current guidelines.
- Screening for influenza vaccine status and vaccinating prior to discharge for patients age 50 and over discharged during the winter.
- Screening for pneumococcal vaccine status and vaccinating prior to discharge for patients age 65 and over.
Treatment of Respiratory Infections
Measure Title
Hospital patients with pneumonia who had blood cultures collected before antibiotics were administered.
Measure Source
Centers for Medicare & Medicaid Services (CMS), Medicare Quality Improvement Organization Program (QIO).
National Table
2_9_2_2.1 Hospital patients with pneumonia who had blood cultures collected before antibiotics were administered, United States, 2005-2010
National Data Source
CMS, QIO.
National Denominator
Discharged patients meeting either of the following criteria: (1) principal diagnosis of pneumonia or (2) secondary diagnosis of pneumonia and a principal diagnosis of either septicemia or respiratory failure who had a blood culture performed during their inpatient stay.
National Numerator
Subset of the denominator who had the blood culture performed prior to antibiotic administration.
State Table
2_9_2_2.2 Hospital patients with pneumonia who had blood cultures collected before antibiotics were administered, by State, United States, 2005-2010
State Data Source
CMS, QIO.
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Estimates are calculated using hospital-level scores.
Treatment of Respiratory Infections
Measure Title
Hospital patients with pneumonia who received the initial antibiotic dose within 6 hours of arrival.
Measure Source
Centers for Medicare & Medicaid Services (CMS), Medicare Quality Improvement Organization Program (QIO).
National Table
2_9_2_3.1 Hospital patients with pneumonia who received the initial antibiotic dose within 6 hours of hospital arrival, United States, 2007-2010
National Data Source
CMS, QIO.
National Denominator
Discharged hospital patients meeting either of the following criteria: (1) principal diagnosis of pneumonia or (2) secondary diagnosis of pneumonia and a principal diagnosis of either septicemia or respiratory failure.
National Numerator
Subset of the denominator who received their first dose of antibiotics within 6 hours after arrival at the hospital.
State Table
2_9_2_3.2 Hospital patients with pneumonia who received the initial antibiotic dose within 6 hours of hospital arrival, by State, United States, 2007-2010
State Data Source
CMS, QIO.
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Estimates are calculated using hospital-level scores.
Treatment of Respiratory Infections
Measure Title
Hospital patients with pneumonia who received the initial antibiotic dose consistent with current recommendations.
Measure Source
Centers for Medicare & Medicaid Services (CMS), Medicare Quality Improvement Organization Program (QIO).
National Table
2_9_2_4.1 Hospital patients with pneumonia who received the initial antibiotic dose consistent with current recommendations, United States, 2005-2010
National Data Source
CMS, QIO.
National Denominator
Discharged hospital patients meeting either of the following criteria: (1) principal diagnosis of pneumonia or (2) secondary diagnosis of pneumonia and a principal diagnosis of either septicemia or respiratory failure.
National Numerator
Subset of the denominator who received an initial antibiotic regimen consistent with current guidelines during the first 24 hours of their hospitalization.
State Table
2_9_2_4.2 Hospital patients with pneumonia who received the initial antibiotic consistent with current recommendations, by State, United States, 2005-2010
State Data Source
CMS, QIO.
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Specification of the denominator of this measure has changed to exclude patients with healthcare-associated pneumonia. Reported rates may not be comparable with those reported in earlier years of the NHQR and NHDR.
Estimates are calculated using hospital-level scores.
Treatment of Respiratory Infections
Measure Title
Hospital patients with pneumonia who received influenza screening or vaccination.
Measure Source
Centers for Medicare & Medicaid Services (CMS), Medicare Quality Improvement Organization Program (QIO).
National Table
2_9_2_5.1 Hospital patients age 50 and over with pneumonia discharged during October-February who received an influenza screening or vaccination, United States, 2005-2010
National Data Source
CMS, QIO.
National Denominator
Medicare patients age 50 and over discharged from an acute care hospital during the months of October, November, December, January, and February meeting either of the following criteria: (1) principal diagnosis of pneumonia or (2) secondary diagnosis of pneumonia and a principal diagnosis of either septicemia or respiratory failure.
National Numerator
Subset of the denominator who were screened for influenza vaccine status and were vaccinated prior to discharge, if indicated.
State Table
2_9_2_5.2 Hospital patients age 50 and over with pneumonia, discharged during October-February, who were screened for influenza vaccine status and were vaccinated prior to discharge, by State, United States, 2005-2010
State Data Source
CMS, QIO.
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Estimates are calculated using hospital-level scores.
Treatment of Respiratory Infections
Measure Title
Hospital patients with pneumonia who received pneumococcal screening or vaccination.
Measure Source
Centers for Medicare & Medicaid Services (CMS), Medicare Quality Improvement Organization Program (QIO).
National Table
2_9_2_6.1 Hospital patients age 65 and over with pneumonia who received pneumococcal screening or vaccination, United States, 2005-2010
National Data Source
CMS, QIO.
National Denominator
Discharged hospital patients age 65 and over meeting either of the following criteria: (1) principal diagnosis of pneumonia or (2) secondary diagnosis of pneumonia and a principal diagnosis of either septicemia or respiratory failure.
National Numerator
Subset of the denominator who were screened for pneumococcal vaccine status and were vaccinated prior to discharge, if indicated.
State Table
2_9_2_6.2 Hospital patients age 65 and over with pneumonia who received pneumococcal screening or vaccination, by State, United States, 2005-2010
State Data Source
CMS, QIO.
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Estimates are calculated using hospital-level scores.
Treatment of Respiratory Infections
Measure Title
Deaths per 1,000 adult hospital admissions with pneumonia.
Measure Source
Agency for Healthcare Research and Quality (AHRQ), Center for Delivery, Organization, and Markets (CDOM), Healthcare Cost and Utilization Project (HCUP), Inpatient Quality Indicators (IQIs).
National Tables
2_9_2_7.1 Deaths per 1,000 hospital admissions with pneumonia, age 18 and over, United States, 2000, 2004-2009
2_9_2_7.2 Deaths per 1,000 hospital admissions with pneumonia, age 18 and over, by race/ethnicity, United States, 2009
2_9_2_7.4 Deaths per 1,000 hospital admissions with pneumonia, age 18 and over, by income, United States, 2000-2009
National Data Source
AHRQ, CDOM, HCUP, Nationwide Inpatient Sample (NIS) and AHRQ Quality Indicators, modified version 4.1.
National Denominator
All discharges age 18 and over with principal diagnosis code of pneumonia, excluding patients transferring to another short-term hospital, obstetric admissions, and cases with a missing discharge disposition.
National Numerator
Subset of the denominator who died.
State Table
2_9_2_7.3 Deaths per 1,000 hospital admissions with pneumonia, age 18 and over, by State, United States, 2000, 2004, 2007-2009
State Data Source
AHRQ, CDOM, HCUP, State Inpatient Databases (SID).
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Rates are adjusted by age, gender, age-gender interactions, major diagnostic category (MDC), all patient refined-diagnosis related group (APR-DRG) risk of mortality score, and transfers to the hospital. When reporting is by age, the adjustment is by gender, MDC, APR-DRG risk of mortality score, and transfers to the hospital; when reporting is by gender, the adjustment is by age, MDC, APR-DRG risk of mortality score, and transfers to the hospital. The AHRQ IQI software was modified to not use the present on admission (POA) indicators (or estimates of the likelihood of POA for secondary diagnosis).
Although not all States participate in the HCUP database, NIS is weighted to give national estimates using weights based on all U.S. community, nonrehabilitation hospitals in the American Hospital Association Annual Survey Database.
SID includes a powerful set of hospital databases from data organizations in participating States. SID contains the universe of the inpatient discharge abstracts in participating States, translated into a uniform format to facilitate multi-State comparisons and analyses. Together, SID encompasses about 90% of all U.S. community hospital discharges. SID contains a core set of clinical and nonclinical information on all patients, regardless of payer, including people covered by Medicare, Medicaid, and private insurance, as well as uninsured people. In addition to the core set of uniform data elements common to all SID, some databases within SID include other elements, such as the patient’s race.
The SID disparities analysis file is designed to provide national estimates on disparities using weighted records from a sample of hospitals from the following 31 States: Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Vermont, Wisconsin, and Wyoming.
Treatment of Respiratory Infections
Measure Title
Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment.
Measure Source
American Thoracic Society.
Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination.
National Tables
2_9_2_8.1 Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment, United States, 2008
2_9_2_8.2 Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment, United States, 2000-2007
2_9_2_8.2a-d Patients with tuberculosis who completed a curative course of treatment within 1 year of initiation of treatment, United States, 2008, by:
- Race.
- Ethnicity.
- Race (foreign born only).
- Ethnicity (foreign born only).
National Data Source
CDC, National Tuberculosis Surveillance System (NTBSS).
National Denominator
U.S. resident population with verified tuberculosis who are eligible to complete therapy within 1 year.
National Numerator
Subset of the denominator completing therapy within 1 year.
Comments
More information regarding current tuberculosis treatment guidelines is available from: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.
For a discussion of completion of tuberculosis therapy, refer to Appendix A of the CDC publication Reported tuberculosis in the United States, 2000, available at: http://www.tbchicago.org/tbguidecdc/SURV/surv2000/pdfs/surv2000combined.pdf [Plugin Software Help].
Specification of race changed in 2003; therefore, results have changed slightly from calculations in previous reports.
Treatment of Respiratory Infections
Measure Title
Bacterial pneumonia admissions per 100,000 adult population in Hawaii.
Measure Source
Agency for Healthcare Research and Quality (AHRQ), Center for Delivery, Organization, and Markets (CDOM), Healthcare Cost and Utilization Project (HCUP), Hawaii State Inpatient Databases (SID) and AHRQ Quality Indicators, version 4.1.
National Table
2_9_2_9.1 Hospital admissions for bacterial pneumonia per 100,000 population, age 18 and over, by race/ethnicity, Hawaii, 2008-2009
National Data Source
AHRQ, CDOM, HCUP, Hawaii SID and AHRQ Quality Indicators, modified version 4.1.
National Denominator
Hospital admissions age 18 and over.
National Numerator
Subset of the denominator with bacterial pneumonia.
Management of Asthma
Measure Title
People with asthma who are taking daily or almost daily preventive medicine.
Measure Source
Agency for Healthcare Research and Quality (AHRQ), Center for Financing, Access, and Cost Trends (CFACT), Medical Expenditure Panel Survey (MEPS).
National Tables
2_9_3_1.1_1 People with current asthma who are taking daily or almost daily (either oral or inhaler) preventive medicine, United States, 2003-2009
2_9_3_1.1_2a-d People with current asthma who are taking daily or almost daily (either oral or inhaler) preventive medicine, United States, 2009 by:
- Race.
- Ethnicity.
- Family income.
- Education.
National Data Source
AHRQ, CFACT, MEPS.
National Denominator
U.S. civilian noninstitutionalized population who currently have active asthma.
National Numerator
Subset of the denominator who report taking preventive medicine on a daily or almost daily basis.
Comments
Estimates are age adjusted to the 2000 U.S. standard population using four age groups: 0-17, 18-44, 45-64, and 65 and over.
Excludes cases for which information on presence of asthma is missing.
Management of Asthma
Measure Title
Hospital admissions for asthma per 100,000 population by age group.
Measure Source
Healthy People 2020.
Agency for Healthcare Research and Quality (AHRQ), Center for Delivery, Organization, and Markets (CDOM), Healthcare Cost and Utilization Project (HCUP), Pediatric Quality Indicators (PDIs)
National Tables
2_9_3_2.1 Admissions for asthma per 100,000 population, age 18 and over, United States, 2000, 2004-2009
2_9_3_2.2 Admissions for asthma per 100,000 population, age 18 and over, by race/ethnicity, United States, 2009
2_9_3_2.4 Admissions for asthma per 100,000 population, age 18 and over, by income, United States, 2000-2009
2_9_3_3.1 Admissions for asthma per 100,000 population, ages 2-17, United States, 2000, 2004-2009
2_9_3_3.2 Admissions for asthma per 100,000 population, ages 2-17, by race/ethnicity, United States, 2009
2_9_3_3.4 Admissions for asthma per 100,000 population, ages 2-17, by income, United States, 2000-2009
2_9_3_4.1 Admissions for asthma per 100,000 population, age 65 and over, United States, 2000, 2004-2009
2_9_3_4.2 Admissions for asthma per 100,000 population, age 65 and over, by race/ethnicity, United States, 2009
2_9_3_4.4 Admissions for asthma per 100,000 population, age 65 and over, by income, United States, 2000-2009
National Data Source
AHRQ, CDOM, HCUP, Nationwide Inpatient Sample (NIS) and AHRQ Quality Indicators, modified version 4.1.
National Denominator
As appropriate to each measure, the U.S. population of children ages 2-17, adults age 18 and over, or adults age 65 and over, excluding admissions with cystic fibrosis or anomalies of the respiratory system, transfers from other institutions, and obstetric admissions.
National Numerator
Subset of the denominator admitted to an acute care or community hospital with a principal diagnosis of asthma.
State Tables
2_9_3_2.3 Admissions for asthma per 100,000 population, age 18 and over, by State, United States, 2000, 2004, 2007-2009
2_9_3_3.3 Admissions for asthma per 100,000 population, age 2-17, by State, United States, 2000, 2004, 2007-2009
2_9_3_4.3 Admissions for asthma per 100,000 population, age 65 and over, by State, United States, 2000, 2004, 2007-2009
State Data Source
AHRQ, CDOM, HCUP, State Inpatient Databases (SID).
State Denominator
Same as national.
State Numerator
Same as national.
Comments
Rates are adjusted by age and gender, using the 2000 U.S. standard population.
Although not all States participate in the HCUP database, NIS is weighted to give national estimates using weights based on all U.S. community, nonrehabilitation hospitals in the American Hospital Association Annual Survey Database.
This measure is referred to as measure RD-2 in Healthy People 2020 documentation.
SID includes a powerful set of hospital databases from data organizations in participating States. SID contains the universe of the inpatient discharge abstracts in participating States, translated into a uniform format to facilitate multi-State comparisons and analyses. Together, SID encompasses about 90% of all U.S. community hospital discharges. SID contains a core set of clinical and nonclinical information on all patients, regardless of payer, including people covered by Medicare, Medicaid, and private insurance, as well as uninsured people. In addition to the core set of uniform data elements common to all SID, some databases within SID include other elements, such as the patient’s race.
The SID disparities analysis file is designed to provide national estimates on disparities using weighted records from a sample of hospitals from the following 31 States: Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Vermont, Wisconsin, and Wyoming.
Management of Asthma
Measure Title
People with asthma who receive written asthma management plans from their health provider.
Measure Source
Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health Interview Survey (NHIS).
National Tables
2_9_3_5.1 People with current asthma who receive written asthma management plans from their health provider, United States, 2009
2_9_3_5.2a-c People with current asthma who receive written asthma management plans from their health provider, United States, 2009, by:
- Race.
- Ethnicity.
- Family income.
National Data Source
CDC, NCHS, NHIS.
National Denominator
U.S. civilian noninstitutionalized population with asthma.
National Denominator
Subset of the denominator who report receiving written asthma management plans from their health provider.
Comments
Estimates are age adjusted to the 2000 U.S. standard population. Age data and health insurance data for those age 65 and over are unadjusted.
5600 Fishers Lane Rockville, MD 20857